Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Gazzin, Silvia ^a   Berengeno, Andrea Lorena ^a   Strazielle, Nathalie ^b   Fazzari, Francesco ^a   Raseni, Alan ^c   Donald Ostrow, J ^d   Wennberg, Richard ^e   Ghersi Egea, Jean François ^b   Tiribelli, Claudio ^a  

^a Centro Studi Fegato   (Italy)

^b UNIVERSITÉ LYON 1   (France)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN FOURTH VENTRICLE; CHOROID PLEXUS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENE CONTROL; GUNN RAT; HETEROZYGOSITY; IN VITRO STUDY; KERNICTERUS; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PUP (RODENT); RAT; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UPREGULATION; ANIMAL; CEREBROSPINAL FLUID; GENE EXPRESSION REGULATION; JAUNDICE; METABOLISM; PROTEIN SYNTHESIS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BILIRUBIN; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID; GENE EXPRESSION REGULATION; JAUNDICE; KERNICTERUS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROTEIN BIOSYNTHESIS; RATS; RATS, GUNN; RNA, MESSENGER;

EID: 79551647689     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016165     Document Type: Article

References (66)

1. Gourley GR (1997) Bilirubin metabolism and kernicterus. Adv Pediatr 44: 173-229.
2. Ostrow JD, Pascolo L, Shapiro SM, Tiribelli C (2003) New concepts in bilirubin encephalopathy. Eur J Clin Invest 33: 988-997.
3. Ostrow JD (1987) Bile pigments and jaundice Marcel Dekker, Inc.
4. Kaplan M, Muraca M, Hammerman C, Rubaltelli F, Vilei MT, et al. (2002) Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Available: http://pediatrics.org/ cgi/content/full/110/4/e47.
5. Shapiro SM, Bhutani VK, Johnson L (2006) Hyperbilirubinemia and kernicterus. Clin Perinatol 33: 387-410.
6. Bosma PJ, Goldhoorn B, Oude Elferink RP, Sinaasappel M, Oostra BA, et al. (1993) A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology 105: 216-220.
7. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, et al. (2000) Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 16: 297-306.
8. Ostrow JD, Mukerjee P, Tiribelli C (1994) Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res 35: 1715-1737.
9. Diamond I, Schmid R (1966) Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system. J Clin Invest 45: 678-689.
10. Takahashi M, Sugiyama K, Shumiya S, Nagase S (1984) Penetration of bilirubin into the brain in albumin-deficient and jaundiced rats (AJR) and Nagase analbuminemic rats (NAR). J Biochem 96: 1705-1712.
11. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM (2006) Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117: 474-485.
12. Wennberg RP (2000) The blood-brain barrier and bilirubin encephalopathy. Cell Mol Neurobiol 20: 97-109.
13. Rodriguez-Baeza A, Reina-de la TF, Poca A, Marti M, Garnacho A (2003) Morphological features in human cortical brain microvessels after head injury: a three-dimensional and immunocytochemical study. Anat Rec A Discov Mol Cell Evol Biol 273: 583-593.
14. Ghersi-Egea JF, Gazzin S, Strazielle N (2009) Blood-brain interfaces and bilirubin-induced neurological diseases. Curr Pharm Des 15: 2893-2907.
15. Liebner S, Kniesel U, Kalbacher H, Wolburg H (2000) Correlation of tight junction morphology with the expression of tight junction proteins in bloodbrain barrier endothelial cells. Eur J Cell Biol 79: 707-717.
16. Lippoldt A, Liebner S, Andbjer B, Kalbacher H, Wolburg H, et al. (2000) Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C. Neuroreport 11: 1427-1431.
17. Nag S (2003) Blood-brain barrier permeability using tracers and immunohistochemistry. Methods Mol Med 89: 133-144.
18. Gazzin S, Strazielle N, Schmitt C, Fevre-Montange M, Ostrow JD, et al. (2008) Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J Comp Neurol 510: 497-507.
19. Ghersi-Egea JF, Leninger-Muller B, Suleman G, Siest G, Minn A (1994) Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 62: 1089-1096.
20. Ghersi-Egea JF, Leininger-Muller B, Cecchelli R, Fenstermacher JD (1995) Blood-brain interfaces: relevance to cerebral drug metabolism. Toxicol Lett 82-83: 645-653.
21. Ghersi-Egea JF, Strazielle N (2001) Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus. Microsc Res Tech 52: 83-88.
22. Lawrenson JG, Reid AR, Finn TM, Orte C, Allt G (1999) Cerebral and pial microvessels: differential expression of gamma-glutamyl transpeptidase and alkaline phosphatase. Anat Embryol (Berl) 199: 29-34.
23. Jette L, Murphy GF, Leclerc JM, Beliveau R (1995) Interaction of drugs with Pglycoprotein in brain capillaries. Biochem Pharmacol 50: 1701-1709.
24. Rigato I, Pascolo L, Fernetti C, Ostrow JD, Tiribelli C (2004) The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin. Biochem J 383: 335-341.
25. Daood M, Tsai C, Ahdab-Barmada M, Watchko JF (2008) ABC transporter (Pgp/ ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 39: 211-218.
26. Virgintino D, Errede M, Girolamo F, Capobianco C, Robertson D, et al. (2008) Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol 67: 50-61.
27. Ostrow JD, Pascolo L, Brites D, Tiribelli C (2004) Molecular basis of bilirubininduced neurotoxicity. Trends Mol Med 10: 65-70.
28. Watchko JF, Daood MJ, Mahmood B, Vats K, Hart C, et al. (2001) Pglycoprotein and bilirubin disposition. J Perinatol 21 Suppl 1: S43-S47.
29. Gunn CH (1938) Hereditary acholuric jaundice in a new mutant strain of rats. J Hered 29: 137-139.
30. Chowdhury JR, Kondapalli R, Chowdhury NR (1993) Gunn rat: a model for inherited deficiency of bilirubin glucuronidation. Adv Vet Sci Comp Med 37: 149-173.
31. Chowdhury JR, Huang TJ, Kesari K, Lederstein M, Arias IM, et al. (1991) Molecular basis for the lack of bilirubin-specific and 3-methylcholanthreneinducible UDP-glucuronosyltransferase activities in Gunn rats. The two isoforms are encoded by distinct mRNA species that share an identical single base deletion. J Biol Chem 266: 18294-18298.
32. Iyanagi T, Watanabe T, Uchiyama Y (1989) The 3-methylcholanthreneinducible UDP-glucuronosyltransferase deficiency in the hyperbilirubinemic rat (Gunn rat) is caused by a -1 frameshift mutation. J Biol Chem 264: 21302-21307.
33. Schmid R, Axelrod J, Hammaker L, Swarm RL (1958) Congenital jaundice in rats, due to a defect in glucuronide formation. J Clin Invest 37: 1123-1130.
34. Keino H, Sato H, Semba R, Aono S, Aoki E, et al. (1985) Mode of prevention by phototherapy of cerebellar hypoplasia in a new Sprague-Dawley strain of jaundiced Gunn rats. Pediatr Neurosci 12: 145-150.
35. Cannon C, Daood MJ, O'Day TL, Watchko JF (2006) Sex-specific regional brain bilirubin content in hyperbilirubinemic Gunn rat pups. Biol Neonate 90: 40-45.
36. Johnson JA, Hayward JJ, Kornguth SE, Siegel FL (1993) Effects of hyperbilirubinaemia on glutathione S-transferase isoenzymes in cerebellar cortex of the Gunn rat. Biochem J 291 (Pt 2): 453-461.
37. Conlee JW, Shapiro SM (1997) Development of cerebellar hypoplasia in jaundiced Gunn rats: a quantitative light microscopic analysis. Acta Neuropathol 93: 450-460.
38. Shapiro SM (2002) Somatosensory and brainstem auditory evoked potentials in the Gunn rat model of acute bilirubin neurotoxicity. Pediatr Res 52: 844-849.
39. Ehrlich P (1883) Sulfadiazobensol, ein Reagens auf Bilirubin. Centr Klin Med 4: 721-723.
40. Fernetti C, Pascolo L, Podda E, Gennaro R, Stebel M, et al. (2001) Preparation of an antibody recognizing both human and rodent MRP1. Biochem Biophys Res Commun 288: 1064-1068.
41. Strazielle N, Belin MF, Ghersi-Egea JF (2003) Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters. AIDS 17: 1473-1485.
42. Strazielle N, Ghersi-Egea JF (1999) Demonstration of a coupled metabolismefflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci 19: 6275-6289.
43. Roca L, Calligaris S, Wennberg RP, Ahlfors CE, Malik SG, et al. (2006) Factors affecting the binding of bilirubin to serum albumins: validation and application of the peroxidase method. Pediatr Res 60: 724-728.
44. Sawasaki Y, Yamada N, Nakajima H (1976) Developmental features of cerebellar hypoplasia and brain bilirubin levels in a mutant (Gunn) rat with hereditary hyperbilirubinaemia. J Neurochem 27: 577-583.
45. Lin S, Wei X, Bales KR, Paul AB, Ma Z, et al. (2005) Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat. Eur J Neurosci 22: 21-27.
46. Tsai CE, Daood MJ, Lane RH, Hansen TW, Gruetzmacher EM, et al. (2002) Pglycoprotein expression in mouse brain increases with maturation. Biol Neonate 81: 58-64.
47. Matsuoka Y, Okazaki M, Kitamura Y, Taniguchi T (1999) Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain. J Neurobiol 39: 383-392.
48. Cesaratto L, Calligaris SD, Vascotto C, Deganuto M, Bellarosa C, et al. (2007) Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref- 1-dependent pathway. J Mol Med 85: 1099-1112.
49. Tell G, Gustincich S (2009) Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cells. Curr Pharm Des 15: 2908-2914.
50. Brito MA, Lima S, Fernandes A, Falcao AS, Silva RF, et al. (2008) Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid. Neurotoxicology 29: 259-269.
51. Brito MA, Rosa AI, Falcao AS, Fernandes A, Silva RF, et al. (2008) Unconjugated bilirubin differentially affects the redox status of neuronal and astroglial cells. Neurobiol Dis 29: 30-40.
52. Felix RA, Barrand MA (2002) P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress. J Neurochem 80: 64-72.
53. Hong H, Lu Y, Ji ZN, Liu GQ (2006) Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells. J Neurochem 98: 1465-1473.
54. Strazielle N, Ghersi-Egea JF (1999) Demonstration of a coupled metabolismefflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci 19: 6275-6289.
55. Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, et al. (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287: G1008-G1016.
56. Jones BR, Li W, Cao J, Hoffman TA, Gerk PM, et al. (2005) The role of protein synthesis and degradation in the post-transcriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2). Mol Pharmacol 68: 701-710.
57. Mediavilla MG, Pascolo L, Rodriguez JV, Guibert EE, Ostrow JD, et al. (1999) Uptake of [(3)H]bilirubin in freshly isolated rat hepatocytes: role of free bilirubin concentration. FEBS Lett 463: 143-145.
58. Corich L, Aranda A, Carrassa L, Bellarosa C, Ostrow JD, et al. (2009) The cytotoxic effect of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells is modulated by the expression level of MRP1 but not MDR1. Biochem J 417: 305-312.
59. Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG, et al. (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269: 27807-27810.
60. Sugiyama D, Kusuhara H, Lee YJ, Sugiyama Y (2003) Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier. Pharm Res 20: 1394-1400.
61. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, et al. (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56: 988-994.
62. Hirrlinger J, Konig J, Keppler D, Lindenau J, Schulz JB, et al. (2001) The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J Neurochem 76: 627-636.
63. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, et al. (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902-5910.
64. Wijnholds J, deLange EC, Scheffer GL, van den Berg DJ, Mol CA, et al. (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 105: 279-285.
65. Wijnholds J, Evers R, van Leusden MR, Mol CA, Zaman GJ, et al. (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 3: 1275-1279.
66. Lorico A, Rappa G, Finch RA, Yang D, Flavell RA, et al. (1997) Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res 57: 5238-5242.